Bookmark

Add to MyYahoo RSS

ARIAD Pharmaceuticals News

News on ARIAD Pharmaceuticals (Ticker: ARIA) continually updated from thousands of sources around the net.

Yesterday | AmericanBankingNews.com

Ariad Pharmaceuticals Director Acquires $4,955,500 in Stock

Ariad Pharmaceuticals Director Alexander J. Denner purchased 850,000 shares of the stock in a transaction that occurred on Friday, August 15th.

Comment?

Related Topix: Biotech, Healthcare Industry

Wed Aug 13, 2014

Hispanic Business

ARIAD Reports Second Quarter 2014 Financial Results and Development Progress

The Company also provided an update on corporate developments (see also , M.D., chairman and chief executive officer of ARIAD.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry

Tue Aug 12, 2014

AmericanBankingNews.com

Ariad Pharmaceuticals Receives Consensus Recommendation of "Hold" from Brokerages

Shares of Ariad Pharmaceuticals have been given an average recommendation of "Hold" by the twenty-three ratings firms that are currently covering the stock, Analyst RN reports .

Comment?

Related Topix: Biotech, Healthcare Industry

AmericanBankingNews.com

Short Interest in Ariad Pharmaceuticals Decreases By 4.0%

Ariad Pharmaceuticals was the recipient of a large decrease in short interest during the month of July.

Comment?

Related Topix: Biotech, Healthcare Industry

Fri Aug 08, 2014

AmericanBankingNews.com

Ariad Pharmaceuticals Given Average Rating of "Hold" by Analysts

Ariad Pharmaceuticals has earned a consensus recommendation of "Hold" from the twenty-three ratings firms that are covering the stock, Stock Ratings Network.com reports .

Comment?

Related Topix: Biotech, Healthcare Industry

Wed Aug 06, 2014

Seeking Alpha

Ariad Pharmaceuticals' (ARIA) CEO Harvey Berger on Q2 2014 Results - Earnings Call Transcript

Thank you for holding for ARIAD Pharmaceuticals' Second Quarter 2014 Financial Results Conference Call.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Oncology

TheStreet.com

Why Ariad Pharmaceuticals (ARIA) Stock Is Down Today

Your browser is not supported. Please upgrade to one of the following browsers: Google Chrome Mozilla Firefox Apple Safari Microsoft Internet Explorer 8+ You may proceed to the site by clicking here , however some pages might not work correctly.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Mozilla, TheStreet

Freshnews

ARIAD Reports Second Quarter 2014 Financial Results and Development Progress

ARIAD Pharmaceuticals, Inc. today reported financial results for the second quarter of 2014, including revenue from sales of Iclusig .

Comment?

Related Topix: Biotech, Healthcare Industry, Health, Lung Cancer

Tue Aug 05, 2014

Business Wire

ARIAD Announces Commercial Agreement for Iclusig (Ponatinib) in Israel

Under the terms of the agreement, ARIAD Pharmaceuticals Ltd will be the Marketing Authorization Holder of Iclusig in Israel, and Medison will be responsible for sales and marketing, medical affairs, regulatory support, as well as obtaining, in collaboration with ARIAD, the pricing and reimbursement approval of Iclusig.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Marketing, Hematology, Oncology, Cambridge, MA

•••
•••
•••
•••
•••

Ashburn Jobs

•••
•••
•••
•••